[{"address1": "175 Innovation Boulevard", "city": "Wilmington", "state": "DE", "zip": "19805", "country": "United States", "phone": "302 467 1280", "website": "https://preludetx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Prelude Therapeutics Incorporated, a clinical-stage precision oncology company, focuses on the discovery and development of novel precision cancer medicines to underserved patients. It is developing PRT3789, a selective degrader of SMARCA2 protein for the treatment of advanced or metastatic solid tumors with loss of SMARCA4 due to truncating mutation and/or deletion; PRT7732, a selective and orally bioavailable SMARCA2 degraders to treat advanced or metastatic solid tumors; and PRT2527, a cyclin-dependent kinase 9 inhibitor for the treatment of advanced solid tumors. The company's CDK9 program is a regulator of cancer-promoting transcriptional programs, including MCL1, MYC, and MYB. Prelude Therapeutics Incorporated was incorporated in 2016 and is based in Wilmington, Delaware.", "fullTimeEmployees": 131, "companyOfficers": [{"maxAge": 1, "name": "Dr. Krishna  Vaddi D.V.M., Ph.D.", "age": 58, "title": "Founder, CEO & Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 881092, "exercisedValue": 0, "unexercisedValue": 12515}, {"maxAge": 1, "name": "Dr. Edna  Huang M.D.", "age": 51, "title": "President & Chief Medical Officer", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 843233, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bryant David Lim J.D.", "age": 53, "title": "CFO, Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 621017, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Aimee  Crombie Ph.D.", "title": "Senior VP and Head of Strategic Planning & Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Madhu  Pudipeddi Ph.D.", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peggy A. Scherle Ph.D.", "age": 62, "title": "Chief Scientific Officer", "yearBorn": 1962, "fiscalYear": 2024, "totalPay": 868617, "exercisedValue": 0, "unexercisedValue": 436567}, {"maxAge": 1, "name": "Ms. Michele  Porreca M.B.A.", "title": "Chief People Officer", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Andrew P. Combs Ph.D.", "age": 57, "title": "Executive VP & Chief Chemistry Officer", "yearBorn": 1967, "fiscalYear": 2024, "totalPay": 562461, "exercisedValue": 0, "unexercisedValue": 399432}, {"maxAge": 1, "name": "Mr. Naveen  Babbar Ph.D.", "title": "Senior Vice President of Translation Medicine", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William B. Novotny M.D.", "title": "Senior Vice President of Clinical Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 7, "boardRisk": 6, "compensationRisk": 9, "shareHolderRightsRisk": 10, "overallRisk": 9, "governanceEpochDate": 1746057600, "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.7643, "open": 0.77, "dayLow": 0.76, "dayHigh": 0.843, "regularMarketPreviousClose": 0.7643, "regularMarketOpen": 0.77, "regularMarketDayLow": 0.76, "regularMarketDayHigh": 0.8042, "payoutRatio": 0.0, "beta": 1.293, "forwardPE": -0.516755, "volume": 31359, "regularMarketVolume": 31359, "averageVolume": 196265, "averageVolume10days": 83450, "averageDailyVolume10Day": 83450, "bid": 0.56, "ask": 0.9935, "bidSize": 2, "askSize": 2, "marketCap": 44056128, "fiftyTwoWeekLow": 0.61, "fiftyTwoWeekHigh": 6.8, "priceToSalesTrailing12Months": 6.2937326, "fiftyDayAverage": 0.7586, "twoHundredDayAverage": 1.97783, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -38001256, "profitMargins": 0.0, "floatShares": 18131719, "sharesOutstanding": 43610200, "sharesShort": 2255923, "sharesShortPriorMonth": 2252233, "sharesShortPreviousMonthDate": 1741910400, "dateShortInterest": 1744675200, "sharesPercentSharesOut": 0.04, "heldPercentInsiders": 0.11366, "heldPercentInstitutions": 0.85399, "shortRatio": 8.83, "shortPercentOfFloat": 0.3059, "impliedSharesOutstanding": 56460500, "bookValue": 1.828, "priceToBook": 0.42685997, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -127827000, "trailingEps": -1.68, "forwardEps": -1.51, "enterpriseToRevenue": -5.429, "enterpriseToEbitda": 0.275, "52WeekChange": -0.812285, "SandP52WeekChange": 0.08001411, "quoteType": "EQUITY", "currentPrice": 0.7803, "targetHighPrice": 5.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.66667, "targetMedianPrice": 5.0, "recommendationMean": 2.25, "recommendationKey": "buy", "numberOfAnalystOpinions": 3, "totalCash": 99074000, "totalCashPerShare": 1.755, "ebitda": -138196000, "totalDebt": 17920000, "quickRatio": 5.007, "currentRatio": 5.175, "totalRevenue": 7000000, "debtToEquity": 17.368, "revenuePerShare": 0.092, "returnOnAssets": -0.45053002, "returnOnEquity": -0.81441003, "grossProfits": 7000000, "freeCashflow": -64804624, "operatingCashflow": -105328000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -19.99671, "financialCurrency": "USD", "symbol": "PRLD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "Prelude Therapeutics Incorporat", "longName": "Prelude Therapeutics Incorporated", "corporateActions": [], "regularMarketTime": 1746724198, "regularMarketChange": 0.016000032, "regularMarketDayRange": "0.76 - 0.8042", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 196265, "fiftyTwoWeekLowChange": 0.1703, "fiftyTwoWeekLowChangePercent": 0.27918032, "fiftyTwoWeekRange": "0.61 - 6.8", "fiftyTwoWeekHighChange": -6.0197, "fiftyTwoWeekHighChangePercent": -0.88525, "fiftyTwoWeekChangePercent": -81.2285, "regularMarketChangePercent": 2.0934231, "regularMarketPrice": 0.7803, "marketState": "REGULAR", "exchange": "NMS", "messageBoardId": "finmb_373775974", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "earningsTimestamp": 1746561901, "earningsTimestampStart": 1746561901, "earningsTimestampEnd": 1746561901, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.68, "epsForward": -1.51, "epsCurrentYear": -1.54367, "priceEpsCurrentYear": -0.5054837, "fiftyDayAverageChange": 0.021700025, "fiftyDayAverageChangePercent": 0.028605359, "twoHundredDayAverageChange": -1.19753, "twoHundredDayAverageChangePercent": -0.60547674, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2020-09-25", "averageAnalystRating": "2.3 - Buy", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1601040600000, "trailingPegRatio": null, "__fetch_time": "2025-05-08"}]